ImageneBio, Inc. Cash Flow-to-Debt Ratio
ImageneBio, Inc. cash flow-to-debt ratio. ImageneBio, Inc. (IMA) has a Cash Flow-to-Debt Ratio of -0.91x as of June 2026, meaning its operating cash flow of $-9.07 Million could theoretically repay -1% of its total liabilities ($9.97 Million) in one year. Check IMA cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of ImageneBio, Inc. (2018–2025)
Cash flow-to-debt ratio of ImageneBio, Inc. from 2018 to 2025. Historical debt coverage capacity for ImageneBio, Inc. across 8 annual periods. Check ImageneBio, Inc. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
ImageneBio, Inc. Cash Flow-to-Debt Ratio by Year (2018–2025)
ImageneBio, Inc. cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for ImageneBio, Inc.. For the full cash flow conversion analysis, see ImageneBio, Inc. (IMA) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.41x | $-47.84 Million | $19.84 Million | ▲ +18.3% |
| 2024 | -2.95x | $-46.00 Million | $15.58 Million | ▲ +17.3% |
| 2023 | -3.57x | $-79.74 Million | $22.34 Million | ▼ -21.8% |
| 2022 | -2.93x | $-74.11 Million | $25.29 Million | ▼ -94.6% |
| 2021 | -1.51x | $-60.25 Million | $40.00 Million | ▼ -973.0% |
| 2020 | -0.14x | $-37.83 Million | $269.45 Million | ▼ -143.2% |
| 2019 | 0.33x | $47.93 Million | $147.44 Million | ▲ +286.3% |
| 2018 | -0.17x | $-11.61 Million | $66.52 Million | — |